Trovato, G., Rossini, D., Ciracì, P., Cavalli, C., Perissinotto, E., Calegari, M. A., Moretto, R., Rebecchi, G., Bergamo, F., Scartozzi, M., Nicastro, A., Tamberi, S., Burgio, V., Fenocchio, E., Antonuzzo, L., Studiale, V., Tortora, G., Morano, F., Salvatore, L., Cremolini, C. (2026). Propensity score–matched analysis of trifluridine-tipiracil plus bevacizumab (FTD/TPI+Bev) vs anti-EGFR re-treatment in pretreated metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3581